Home | | Paediatrics | Paediatrics: Alpha1-antitrypsin deficiency

Chapter: Paediatrics: Gastroenterology and nutrition

Paediatrics: Alpha1-antitrypsin deficiency

Alpha1-antitrypsin is a serum protease inhibitor responsible for control-ling inflammatory cascades.

Alpha1-antitrypsin deficiency

 

Alpha1-antitrypsin is a serum protease inhibitor responsible for control-ling inflammatory cascades.

 

•   It is the commonest genetic cause of liver disease in children, with autosomal dominant inheritance. Prevalence is 1:2000 to 1:7000.

•   Genetic variants are identified by enzyme electrophoretic mobility as medium (M), slow (S), or very slow (Z). S is associated with 760% Alpha1-antitrypsin level of normal; Z 715%. Normal genotype is designated PiMM. Only PiZZ individuals are at risk of liver disease.

 

Presentation

 

•   Cholestasis in infancy, may progress to liver failure.

•   Cirrhosis can occur in late childhood to adult. Chronic liver disease affects 25% of patients in late adulthood.

•   Pulmonary emphysema is the commonest presentation in adulthood.

 

Diagnosis

•   Serum A1-antitrypsin level d.

•   Phenotyping by enzyme isoelectric focusing (see Alpha1-antitrypsin deficiency).

 

Treatment

 

•   Supportive treatment of liver complications.

 

•   Strongly advise against smoking.

 

•   Liver transplant for end-stage liver failure.

 

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Paediatrics: Gastroenterology and nutrition : Paediatrics: Alpha1-antitrypsin deficiency |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.